Keya Medical, a leading medical technology manufacturer, has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
This investment is the fourth large-scale funding round that Keya Medical has completed within the past year, bringing funding to over $110 million in 2020. The financing will support Keya Medical’s AI product development and global business expansion in the new year.

Keya Medical is developing medical solutions using deep learning for cardiology, neurology, pulmonology, and other specialties. Keya Medical’s flagship product, DeepVessel FFR, is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CTA) scans. In 2020, DeepVessel FFR became the first AI software medical device to receive regulatory clearance from the Chinese National Medical Products Administration. The company also received U.S. Food & Drug Administration 510(k) clearance for the intracranial hemorrhage triage software, CuraRad®-ICH. The company will continue to develop products using AI that support healthcare delivery organizations in providing better patient care.

Keya Medical is committed to working with healthcare systems worldwide to develop medical AI products based on real clinical needs. Keya Medical welcomes clinical collaborators to help accelerate progress.

About Keya Medical
Keya Medical is a medical technology manufacturer that develops AI applications that enable healthcare delivery organizations to provide better patient care. Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world. Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are widely used in Chinese hospitals, coronary catheterization labs, and imaging centers. To learn more about Keya Medical, follow us on LinkedIn and Twitter.